Skip to content
healthcare.dev

AllergiClear-M

NDC 68703-341, Adrenalinum, Calcarea fluorica, Calcarea phosphorica, Euphrasia officinalis, Histaminum hydrochloricum, Kali muriaticum, Natrum muriaticum, Silicea, liquid, from Silver Star Brands.

Product NDC
68703-341
Status
Listed
Labeler
Silver Star Brands
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68703-341 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CALCIUM PHOSPHATE8 [hp_X]/59mL
  • CALCIUM FLUORIDE8 [hp_X]/59mL
  • EUPHRASIA OFFICINALIS LEAF4 [hp_X]/59mL
  • EPINEPHRINE7 [hp_C]/59mL
  • HISTAMINE DIHYDROCHLORIDE7 [hp_C]/59mL
  • SILICON DIOXIDE8 [hp_X]/59mL
  • SODIUM CHLORIDE8 [hp_X]/59mL
  • POTASSIUM CHLORIDE8 [hp_X]/59mL

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Blood Coagulation Factor [EPC]; Calcium [CS]; Catecholamine [EPC]; Catecholamines [CS]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Potassium Compounds [CS]; Potassium Salt [EPC]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
68703-341-026870303410259 mL in 1 BOTTLE, DROPPER (68703-341-02)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 68703-341 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68703-341 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68703-341. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.